Skip to main content
. 2021 Apr 16;13:17588359211006983. doi: 10.1177/17588359211006983

Figure 1.

Figure 1.

Randomization and treatment schedule. M, C, ASS (BR) arm: initial BR followed by cisplatin-pemetrexed chemotherapy combined with bevacizumab for eligible patients; ChT arm: cisplatin-pemetrexed ChT combined with bevacizumab for eligible patients with BR only at cerebral disease progression.

ASS, assessment; BR, brain radiotherapy; C, cycle of chemotherapy; ChT, chemotherapy; M, chemotherapy maintenance; R, randomization.